Stay updated with breaking news from Genetic Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sancti Spíritus, Cuba. Dec 19 (Prensa Latina) For the first time in Cuba, Heberprot-P, a national growth factor, was successfully applied to a pediatric patient prior to a skin transplant in this central province, according to specialists.
Immusoft, a Seattle-based biotech company, has become the first to genetically engineer B cells and test them in a patient with a genetic disorder.
The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.
In a November article in Science magazine, journalist Rachael Zamzow informs us that many social scientists believe that every published paper should
B cells are prolific producers of antibodies, but for the first time, scientists have modified them to make other proteins to counteract a serious genetic disease.